Vimta Labs profit and loss

Latest FY26

Revenue: ₹407cr+18.4% on FY25
EBITDA: ₹142cr+16.0% on FY25
Net profit: ₹77.5cr+15.1% on FY25
EPS: ₹17.40−42.5% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	419	407	344	313	315	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	11.1	9.0	4.2	4.0	3.5
	430	416	348	317	319
	84.7	80.8	71.4	75.4	73.4
	0.0	0.0	0.0	0.1	0.1
	116	114	97.0	98.5	90.4
	1.1	1.2	1.9	2.1	2.6
	46.5	43.8	35.3	34.0	30.5
	73.0	70.6	53.6	55.2	57.7
	321	311	259	265	255
	145	142	122	83.6	93.5
	98.7	97.7	86.7	49.6	63.0
Profit
	109	106	89.0	51.5	63.8
	−1.6	−1.6	0.0	0.0	0.0
	107	104	89.0	51.5	63.8
	25.6	26.5	21.0	16.1	18.8
	1.7	−0.1	1.3	−3.4	−2.2
	27.4	26.4	22.2	12.7	16.5
	79.7	77.5	67.3	38.8	47.3
	79.7	77.5	66.8	38.8	47.3
	0.0	0.0	0.6	0.0	0.0
	−0.1	−0.1	−0.0	−0.2	−0.0
	79.6	77.5	67.3	38.6	47.3
Per share
	₹17.86	₹17.40	₹30.28	₹17.52	₹21.37
	₹17.66	₹17.20	₹29.86	₹17.26	₹20.96
Continuing & discontinued operations
	0.0	0.0	1.4	0.0	0.0
	0.0	0.0	0.8	0.0	0.0
Other comprehensive income — detail
	−0.1	−0.1	−0.0	—	—
	−0.1	−0.1	−0.1	−0.3	−0.0
	−0.0	−0.0	−0.0	—	—
	—	—	—	−0.1	−0.0
Per share — as-filed variants
	₹17.86	₹17.40	₹30.02	₹17.52	₹21.37
	₹17.66	₹17.20	₹29.60	₹17.26	₹20.96
	₹0.00	₹0.00	₹0.26	₹0.00	₹0.00
	₹0.00	₹0.00	₹0.26	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	334	326	273	237	242
	79.8%	80.2%	79.2%	75.9%	76.7%
Adjusted (ex-exceptional items) — derived
	109	106	89.0	51.5	63.8
	−1.6	−1.6	0.0	0.0	0.0
	80.9	78.7	67.3	38.8	47.3
	₹18.13	₹17.67	₹30.28	₹17.52	₹21.37

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

VIMTALABS₹519.80

Vimta Labs Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersSUVEN TAKEMcap ₹2,322 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	315.1	312.9	344.0	407.3	418.8
Other Income	3.5	4.0	4.2	9.0	11.1
Total Income	318.6	316.9	348.2	416.3	429.9
Expenses
+ Cost of Materials Consumed	73.4	75.4	71.4	80.8	84.7
+ Changes in Inventories	0.1	0.1	0.0	0.0	0.0
+ Employee Benefit Expense	90.4	98.5	97.0	114.4	116.0
+ Finance Costs	2.6	2.1	1.9	1.2	1.1
+ Depreciation & Amortisation	30.5	34.0	35.3	43.8	46.5
+ Other Expenses	57.7	55.2	53.6	70.6	73.0
Total Expenses	254.8	265.4	259.2	310.7	321.2
EBITDA	93.5	83.6	121.9	141.5	145.1
EBIT	63.0	49.6	86.7	97.7	98.7
Profit
PBT before Exceptional Items	63.8	51.5	89.0	105.6	108.6
+ Exceptional Items	0.0	0.0	0.0	-1.6	-1.6
Pretax Income	63.8	51.5	89.0	104.0	107.0
+ Current Tax	18.8	16.1	21.0	26.5	25.6
+ Deferred Tax	-2.2	-3.4	1.3	-0.1	1.7
Tax Expense	16.5	12.7	22.2	26.4	27.4
Net Income	47.3	38.8	67.3	77.5	79.7
+ Net Income — Continuing Ops	47.3	38.8	66.8	77.5	79.7
+ Net Income — Discontinued Ops	0.0	0.0	0.6	0.0	0.0
+ Other Comprehensive Income	-0.0	-0.2	-0.0	-0.1	-0.1
Total Comprehensive Income	47.3	38.6	67.3	77.5	79.6
Per Share
Basic EPS	21.37	17.52	30.28	17.40	17.86
Diluted EPS	20.96	17.26	29.86	17.20	17.66
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	1.4	0.0	0.0
+ Tax — Discontinued Operations	0.0	0.0	0.8	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.0	-0.1	-0.1
+ Items NOT to be Reclassified to P&L	-0.0	-0.3	-0.1	-0.1	-0.1
+ Tax on Items NOT to be Reclassified	—	—	-0.0	-0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	-0.1	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	21.37	17.52	30.02	17.40	17.86
Diluted EPS — Continuing Operations	20.96	17.26	29.60	17.20	17.66
Basic EPS — Discontinued Operations	0.00	0.00	0.26	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.26	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	241.6	237.4	272.5	326.5	334.1
Gross Margin %	76.68	75.87	79.23	80.16	79.79
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	63.8	51.5	89.0	105.6	108.6
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-1.6	-1.6
Net Income Adj (tax-effected)	47.3	38.8	67.3	78.7	80.9
EPS Adj	21.37	17.52	30.28	17.67	18.13
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	4.4	4.4	4.4	8.9	8.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.